MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023
31 Outubro 2023 - 5:00PM
MannKind Corporation (Nasdaq: MNKD) will release
its 2023 third quarter financial results and year to date financial
results and its management will host a conference call to discuss
these results and corporate updates at 5:00 PM (Eastern Time) on
Tuesday, November 7, 2023.
Presenting from the Company will be its Chief Executive Officer,
Michael Castagna, and Chief Financial Officer, Steven Binder.
Those interested in listening to the conference call live via
the Internet may do so by visiting the Company's website at
https://investors.mannkindcorp.com/events-and-presentations under
Events & Presentations.
About MannKind CorporationMannKind Corporation
(Nasdaq: MNKD) focuses on the development and commercialization of
innovative therapeutic products and devices to address serious
unmet medical needs for those living with endocrine and orphan lung
diseases.
We are committed to using our formulation capabilities and
device engineering prowess to lessen the burden of diseases such as
diabetes, pulmonary arterial hypertension (PAH) and nontuberculous
mycobacterial (NTM) lung disease. Our signature technologies –
dry-powder formulations and inhalation devices – offer rapid and
convenient delivery of medicines to the deep lung where they can
exert an effect locally or enter the systemic circulation.
With a passionate team of Mannitarians collaborating nationwide,
we are on a mission to give people control of their health and the
freedom to live life.
Please visit mannkindcorp.com to learn more, and follow us
on LinkedIn, Facebook, Twitter or Instagram.
For MannKind: Rose Alinaya,
Investor Relations(818) 661-5000Email: ir@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
MannKind (NASDAQ:MNKD)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024